Roeder Friederike, Adegnika Olouyomi Scherif, Honkpehedji Yabo Josiane, Huth Manuel, Lell Bertrand, Adegnika Ayôla Akim, Lopes-Rafegas Iris, Sicuri Elisa
Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
ISGlobal, Barcelona, Spain.
Int J Epidemiol. 2025 Aug 18;54(5). doi: 10.1093/ije/dyaf140.
Coinciding with the SARS-CoV-2 pandemic, malaria cases and malaria-related deaths increased globally between 2020 and 2022. However, evidence linking the pandemic to increased malaria burden remains ambiguous. We assessed the extent to which an observed malaria resurgence in Lambaréné, Gabon, can be associated with pandemic-related disruptions in malaria control programmes.
Using observational data from two tertiary referral hospitals, spanning 2018 to early 2023, we applied autoregressive integrated moving average (ARIMA) models in an interrupted time series (ITS) framework to test for changes in trends and levels following the onset of the pandemic. The primary outcome is the monthly malaria diagnosis rate (per 1000 all-cause hospital diagnoses). As a sub-analysis, we focused on monthly maternal malaria incidence.
Following an initial drop (-47.32, P = 0.031), potentially due to risk-averse behaviours, the malaria diagnosis rate gradually and concavely increased (linear term: 7.32, P = 0.001; squared term: -0.19, P = 0.001) to a peak above pre-pandemic levels. Additional analyses suggest that this resurgence was likely driven by disruptions to malaria control activities and a waning efficacy of malaria control tools administered pre-pandemic. Conversely, a resurgence in maternal malaria incidence was not estimated.
Findings align with several national and global descriptive reports, but add a more detailed understanding of underlying dynamics, therefore reinforcing the importance of maintaining malaria control in the general population. The absence of a meaningful increase in maternal malaria provides some reassurance that malaria in pregnancy-specific control remained unchanged during the SARS-CoV-2 pandemic. However, observed peaks in post-pandemic maternal malaria incidence should raise concerns given the risks that malaria poses to this group.
在2020年至2022年期间,随着新型冠状病毒肺炎(SARS-CoV-2)大流行,全球疟疾病例和疟疾相关死亡人数有所增加。然而,将大流行与疟疾负担增加联系起来的证据仍不明确。我们评估了加蓬兰巴雷内观察到的疟疾复发在多大程度上可能与疟疾控制项目中与大流行相关的干扰有关。
利用2018年至2023年初两家三级转诊医院的观察数据,我们在中断时间序列(ITS)框架中应用自回归积分移动平均(ARIMA)模型,以测试大流行开始后趋势和水平的变化。主要结局是每月疟疾诊断率(每1000例全因医院诊断)。作为一项子分析,我们重点关注每月孕产妇疟疾发病率。
在最初下降(-47.32,P = 0.031)之后,这可能是由于规避风险行为导致,疟疾诊断率逐渐呈凹形上升(线性项:7.32,P = 0.001;平方项:-0.19,P = 0.001),达到高于大流行前水平的峰值。进一步分析表明,这种复发可能是由疟疾控制活动的中断以及大流行前使用的疟疾控制工具效力下降所驱动。相反,未估计出孕产妇疟疾发病率的复发情况。
研究结果与多项国家和全球描述性报告一致,但对潜在动态有了更详细的了解,因此强化了在普通人群中维持疟疾控制的重要性。孕产妇疟疾没有出现显著增加这一点让人放心,即特定于妊娠的疟疾控制在SARS-CoV-2大流行期间保持不变。然而,鉴于疟疾对该群体构成的风险,大流行后孕产妇疟疾发病率出现的峰值应引起关注。